chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site bruising
Clinical narrative: Bruising at Injection site; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Bruising at Injection site) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.    Co-suspect product included non-company product ABALOPARATIDE (TYMLOS) injection for Osteoporosis.    Concurrent medical conditions included Osteoporosis. Concomitant products included IBUPROFEN and OXYCODONE HYDROCHLORIDE (OXYCONTIN) for an unknown indication.   On 18-Jun-2021, the patient started ABALOPARATIDE (TYMLOS) (Subcutaneous) 80 microgram once a day. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jul-2021, the patient experienced VACCINATION SITE BRUISING (Bruising at Injection site) and HEADACHE (Headache). At the time of the report, VACCINATION SITE BRUISING (Bruising at Injection site) had resolved and HEADACHE (Headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Expiry date of Tymlos was Jun-2021 and reaction attributed by it were reported as forgot to push green button on Tymlos pen (Wrong technique in product usage process) on 13-Jul-2021 and administered 2 doses of Tymlos on same day (Overdose) on 14-Jul-2021.  Concomitant medication included unspecified steroid injection on back.  No treatment medication was reported by reporter.  No further information was expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swelling face
Clinical narrative: Rash all over her body, rash not really itchy which spread to the legs; Rash on the upper part of abdomen; Face swelled up again; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Face swelled up again), RASH (Rash all over her body, rash not really itchy which spread to the legs) and RASH (Rash on the upper part of abdomen) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067E21(LI)A) for COVID-19 vaccination.     The patient's past medical history included Dermal filler injection (Botox and Juvederm Treatment since 4 years) since an unknown date. Concomitant products included ABATACEPT (ORENCIA), BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT), SALBUTAMOL SULFATE (PROAIR [SALBUTAMOL SULFATE]), THYROID (ARMOUR THYROID), DULOXETINE HYDROCHLORIDE (CYMBALTA) and VITAMINS NOS for an unknown indication.    On 03-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Sep-2021, the patient experienced SWELLING FACE (Face swelled up again). On 24-Sep-2021, the patient experienced RASH (Rash on the upper part of abdomen). On 26-Sep-2021, the patient experienced RASH (Rash all over her body, rash not really itchy which spread to the legs). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, SWELLING FACE (Face swelled up again), RASH (Rash all over her body, rash not really itchy which spread to the legs) and RASH (Rash on the upper part of abdomen) outcome was unknown.            This case was linked to MOD-2021-333742 (Patient Link).
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site pain (arm sore at the injection site) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 048A21A and 041B21A) for COVID-19 vaccination. No medical history reported. On Mar 23, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 20, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 23, 2021, patient had vaccination site pain/arm sore at the injection site (medically significant). At the time of the report, vaccination site pain (arm sore at the injection site) outcome: unknown. The reporter did not provide any causality assessments, concomitant medications or treatment information. This case linked to MOD-2021-333763 (patient link). Sender's comments: This case concerns a 26 year-old male patient with no reported medical history, who experienced the expected non-serious event of vaccination site pain. The event occurred on the same day as the first dose of mRNA-1273 vaccine. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. The seriousness of criteria of medically significant was overridden based on medical judgement and review of source document that does not include information supporting seriousness criteria.
Age: 74.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case reported by an other healthcare professional, describes the occurrence of administered expired product (vaccine administered after 11 days of puncturing the vial) in a 74-year-old patient, of unknown gender, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 006C21A) for COVID-19 immunization. No medical history reported. On Aug 10, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Aug 10, 2021, patient administered expired product (vaccine administered after 11 days of puncturing the vial). On Aug 10, 2021, patient administered expired product (vaccine administered after 11 days of puncturing the vial) resolved. The reporter did not provide any causality assessments, concomitant medication or treatment information. Most recent follow-up information incorporated: On Sep 28, 2021: Follow-up received contained updated event verbatim.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Vaccination complication
Clinical narrative: Major reaction/little bit of a reaction but now it was really bad/looked deformed; Everything seems amplified; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Major reaction/little bit of a reaction but now it was really bad/looked deformed) and FEELING ABNORMAL (Everything seems amplified) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088P/D21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ABATACEPT (ORENCIA), BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT), SALBUTAMOL SULFATE (PROAIR [SALBUTAMOL SULFATE]), THYROID (ARMOUR THYROID), DULOXETINE HYDROCHLORIDE (CYMBALTA) and VITAMINS NOS for an unknown indication.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Aug-2021, the patient experienced VACCINATION COMPLICATION (Major reaction/little bit of a reaction but now it was really bad/looked deformed) and FEELING ABNORMAL (Everything seems amplified). At the time of the report, VACCINATION COMPLICATION (Major reaction/little bit of a reaction but now it was really bad/looked deformed) and FEELING ABNORMAL (Everything seems amplified) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       On 09-Aug-2021,Patient received Botox and Guvederm treatment after first dose. Patient had this kind of treatment for 4 years and normally had little bit of reaction.  No treatment information was provided.   This case was linked to MOD-2021-333709 (Patient Link).
Age: 55.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered after 9 days of puncturing the vial; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 9 days of puncturing the vial) in a 55-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 9 days of puncturing the vial). On 11-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 9 days of puncturing the vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up received contains updated event verbatim.
Age: 79.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered after 11 days of puncturing the vial; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 11 days of puncturing the vial) in a 79-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 11 days of puncturing the vial). On 13-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 11 days of puncturing the vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up received contains updated event verbatim.
Age: 40.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered after 11 days of puncturing the vial; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 11 days of puncturing the vial) in a 40-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 11 days of puncturing the vial). On 13-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 11 days of puncturing the vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications details were provided. No treatment medications details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up received contains updated event verbatim.
Age: 27.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 27-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 17-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that the patient took the vaccine on 17-Jun-2021 after 6 days from first puncture.  Concomitant medications were not reported. No treatment information was provided.
Age: 27.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered as if it had a preservative; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered as if it had a preservative) in a 27-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered as if it had a preservative). On 13-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered as if it had a preservative) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported. Vaccine was administered after 14 days from the first puncture.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Non significant FU document received on 29-Sep-2021 included no new information.
Age: 49.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 49-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 18-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided. No Treatment medications were reported. Reporter has stated that the time from first puncture was 7 days. Reporter has stated that they were looking for a decision as to whether these doses can be counted or if the provider needs to contact the patients for re-administration of the doses.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Non-significant FU added.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Tired; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired) and PAIN IN EXTREMITY (Sore arm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) for Anticoagulant therapy.    On 14-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tired) and PAIN IN EXTREMITY (Sore arm). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, FATIGUE (Tired) and PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Clopidogrel (Plavix) used as blood thinners.   This case was linked to MOD-2021-333836 (Patient Link).
Age: 67.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 18-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported. No treatment medications were provided.  The vaccine was administered after 7 days of first puncture.  The Moderna vaccine was used as though it had preservative, just like flu multi-dose vials.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up received contains no significant information.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Angiogram, Catheterisation cardiac, Cerebrovascular accident, Computerised tomogram head
Clinical narrative: Patient had acute myocardial infarction 6/8/21, approximately 2.5 months after vaccine.  6 days later (6/14/21) he had CVA.  Following that he has had, per his report, 2 more CVAs (I can find clear documentation of one of those events 6/24/21).  Following that event he had acute pulmonary embolism 9/10/2021 with additional finding of DVT.  Prior to vaccination he had no history of MI, CVA, or DVT/PE
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram neck, Deep vein thrombosis, Magnetic resonance imaging head, Pulmonary embolism
Clinical narrative: Patient had acute myocardial infarction 6/8/21, approximately 2.5 months after vaccine.  6 days later (6/14/21) he had CVA.  Following that he has had, per his report, 2 more CVAs (I can find clear documentation of one of those events 6/24/21).  Following that event he had acute pulmonary embolism 9/10/2021 with additional finding of DVT.  Prior to vaccination he had no history of MI, CVA, or DVT/PE
Age: 56.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine administered as if it had a preservative; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine administered as if it had a preservative) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine administered as if it had a preservative). On 18-Jun-2021, EXPIRED PRODUCT ADMINISTERED (vaccine administered as if it had a preservative) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Vaccine was administered after 7 days of first puncture of vial. No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Non-significant FU added.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Energy increased, Fatigue, Feeling abnormal
Clinical narrative: Day 1.      After 5 hours So tired could not stay awake but felt fine                    Woke up at 12:30 am burning up, achey, massive headache, swollen vaccination site HOT to touch Day 2.      Slept entire day..same as above Day 3.       Same symptoms, no fever, WEAK, foggy feeling, dizzy, throbbing headache Day 4.       I thought I was feel a bit more energy but then became SO nauseous , vomiting throughout the day and early evening Day 5.     Woke up in a burst of energy, worked out?back to myself ?.by 5pm.. fatigue and massive headache returned Day 6/7.    More energy (not  normal). Foggy head, massive headache, fatigue   *I am very active, exercising 6 days a week, eat vegetarian diet, healthy lifestyle.  Today has been a week and I am just not feeling myself?not comfortable driving due to a foggy/dizzy/headache feeling that has not subsided.   I do not believe that I need doctor or care beyond Advil/Tylenol/hydration but I am not myself.  Could be some bug and timing is exact same but I do not believe so.   Sill grateful to be vaccinated!  I take care of my 86 year old mom and feel  safe together with her!
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Impaired driving ability, Nausea, Pain, Sleep disorder
Clinical narrative: Day 1.      After 5 hours So tired could not stay awake but felt fine                    Woke up at 12:30 am burning up, achey, massive headache, swollen vaccination site HOT to touch Day 2.      Slept entire day..same as above Day 3.       Same symptoms, no fever, WEAK, foggy feeling, dizzy, throbbing headache Day 4.       I thought I was feel a bit more energy but then became SO nauseous , vomiting throughout the day and early evening Day 5.     Woke up in a burst of energy, worked out?back to myself ?.by 5pm.. fatigue and massive headache returned Day 6/7.    More energy (not  normal). Foggy head, massive headache, fatigue   *I am very active, exercising 6 days a week, eat vegetarian diet, healthy lifestyle.  Today has been a week and I am just not feeling myself?not comfortable driving due to a foggy/dizzy/headache feeling that has not subsided.   I do not believe that I need doctor or care beyond Advil/Tylenol/hydration but I am not myself.  Could be some bug and timing is exact same but I do not believe so.   Sill grateful to be vaccinated!  I take care of my 86 year old mom and feel  safe together with her!
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth, Vomiting
Clinical narrative: Day 1.      After 5 hours So tired could not stay awake but felt fine                    Woke up at 12:30 am burning up, achey, massive headache, swollen vaccination site HOT to touch Day 2.      Slept entire day..same as above Day 3.       Same symptoms, no fever, WEAK, foggy feeling, dizzy, throbbing headache Day 4.       I thought I was feel a bit more energy but then became SO nauseous , vomiting throughout the day and early evening Day 5.     Woke up in a burst of energy, worked out?back to myself ?.by 5pm.. fatigue and massive headache returned Day 6/7.    More energy (not  normal). Foggy head, massive headache, fatigue   *I am very active, exercising 6 days a week, eat vegetarian diet, healthy lifestyle.  Today has been a week and I am just not feeling myself?not comfortable driving due to a foggy/dizzy/headache feeling that has not subsided.   I do not believe that I need doctor or care beyond Advil/Tylenol/hydration but I am not myself.  Could be some bug and timing is exact same but I do not believe so.   Sill grateful to be vaccinated!  I take care of my 86 year old mom and feel  safe together with her!
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Hair loss
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram abnormal, Anticoagulant therapy, Chest pain, Computerised tomogram thorax abnormal, Dyspnoea
Clinical narrative: Dyspnea and Chest pain, Pulmonary Emboli, Apixaban, admitted to hospital for further workup
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary embolism
Clinical narrative: Dyspnea and Chest pain, Pulmonary Emboli, Apixaban, admitted to hospital for further workup
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Day after 2nd dose/fully vaccinated severe hives over body.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Day after vaccine severe urticaria on torso, bilateral abdominal sides. Urticaria has occurred daily since with areas ranging from groin, legs, ankles, torso, side of torso and chest
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Condition aggravated, Joint noise, Joint stiffness, Musculoskeletal stiffness
Clinical narrative: Joint pain and stiffness. Have used over the counter arthritis rubs and ointments. I had I stiff/ trigger finger before vaccine now all my finger hurt and most are stiff and click. My shoulders, elbows, knees, ankles and toes are hurting, stiff and clicking. I don?t know if this condition is permanent, but I am still dealing with it.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Trigger finger
Clinical narrative: Joint pain and stiffness. Have used over the counter arthritis rubs and ointments. I had I stiff/ trigger finger before vaccine now all my finger hurt and most are stiff and click. My shoulders, elbows, knees, ankles and toes are hurting, stiff and clicking. I don?t know if this condition is permanent, but I am still dealing with it.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Extreme arm pain. Radiates from neck down to elbow. This pain is worse than when I had 2 c-sections! Tylenol and ibuprofen do not even touch this pain.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Pain
Clinical narrative: headache, chills, fever, nausea, body aches, fatigue
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: headache, chills, fever, nausea, body aches, fatigue
Age: 63.0
Sex: F
Vaccine: FLU4
Symptoms: Hypoaesthesia, Swelling face, Urticaria
Clinical narrative: swelling/ numbness in left cheek; hives throughout body
Age: 51.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used, 7 days from first puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used, 7 days from first puncture) in a 51-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used, 7 days from first puncture). On 18-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used, 7 days from first puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported.  No treatment medications was reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow-up received is Non-significant.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash pruritic
Clinical narrative: RASH DEVELOPMENT IN ABDOMINAL AREA, THEN BOTH CALF, THEN LEGS AND ARMS, THEN GENERALIZED RASH WITH SEVERE ITCH
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Inflammation
Clinical narrative: Feeling numb/uncomfortable feeling just under my left rib cage...feels like my spleen is enlarged. It started yesterday and am wondering if it's normal and will go away/subside in the next few days. It doesn't hurt, just notice that it feels a little inflamed.
Age: 28.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered after 14 days of puncturing the vial; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 14 days of puncturing the vial) in a 28-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 14 days of puncturing the vial). On 13-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 14 days of puncturing the vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up received contains updated event verbatim.
Age: 84.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 84-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 25-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported. No treatment medications were provided.  The vaccine was administered after 7 days of first puncture.  The Moderna vaccine was used as though it had preservative, just like flu multi-dose vials.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up received and contains non significant information.
Age: 81.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered 16 days after first puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered 16 days after first puncture) in an 81-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered 16 days after first puncture). On 18-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered 16 days after first puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up contains no new information.
Age: 38.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 38-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 18-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided. No Treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up information included no new information.
Age: 82.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered after 3 days of puncturing the vial; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 3 days of puncturing the vial) in an 82-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 3 days of puncturing the vial). On 20-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 3 days of puncturing the vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported. No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up received contains updated event verbatim.
Age: 83.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine administered 7 days after first puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine administered 7 days after first puncture) in an 83-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine administered 7 days after first puncture). On 25-Jun-2021, EXPIRED PRODUCT ADMINISTERED (vaccine administered 7 days after first puncture) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.   This case was linked to MOD-2021-332855 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow-up  Attached: No new information.
Age: 26.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered 3 days after puncturing the vial; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered 3 days after puncturing the vial) in a 26-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered 3 days after puncturing the vial). On 20-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered 3 days after puncturing the vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up contains updated event verbatim.
Age: 69.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 20-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that, first dose of vaccine was administered after 3 days from first  puncture.  No Concomitant medication was reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up information received contains No significant information.
Age: 88.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 88-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 05-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported. No treatment medications were provided.  The vaccine was administered after 3 days of first puncture.  The Moderna vaccine was used as though it had preservative, just like flu multi-dose vials.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up information was received include no new information.
Age: 27.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used vial punctured before 24 hours of administration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used vial punctured before 24 hours of administration) in a 27-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used vial punctured before 24 hours of administration). On 26-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used vial punctured before 24 hours of administration) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information reported. No treatment medication information reported.   This case was linked to MOD-2021-332841 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up information was received include no new information.
Age: 67.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine administered 11 days after first puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine administered 11 days after first puncture) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine administered 11 days after first puncture). On 07-Sep-2021, EXPIRED PRODUCT ADMINISTERED (vaccine administered 11 days after first puncture) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.   This case was linked to MOD-2021-332745.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow-up information received contain No new information (NNI).
Age: 68.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine administered 1 day after puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine administered 1 day after puncture) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine administered 1 day after puncture). On 03-Aug-2021, EXPIRED PRODUCT ADMINISTERED (vaccine administered 1 day after puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.   This case was linked to MOD-2021-332851 .   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow-up received include no new information.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Lip swelling, Oedema peripheral
Clinical narrative: Swelling under left armpit began 2 days after vaccination and still continues 5 days after vaccination. Swelling has gone down some. Slight swelling under right armpit as well. 5 days after vaccination woke to swollen bottom lip. Some Chet pain 2 days after vaccination but that has subsided. Joint pain elbows and knees.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Pyrexia, Rash erythematous
Clinical narrative: Fever of 102 degrees for 18 to 24 hours. Red rash at injection site lasting several days. This was my second shot.
Age: 36.0
Sex: F
Vaccine: TDAP
Symptoms: Exposure during pregnancy, Injection site pain, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: Patient is 33 week pregnant , estimated due date December. No reaction after the injection. Arm was sore at injection site that was gone after 1½ day then additional  during Sunday patient both hands/ fingers are very sore, does not hurt when stationary, but sore/stiff when curling fingers and holding things.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Fatigue, Pain, Pyrexia
Clinical narrative: Extreme body pain, aches fatigue and mild fever that have been lasting now 3 days. The second dose I had a worse reaction but it lasted about 6-8 hours and stopped. This one is continuing on.  I am reporting so you have this as information. I am not seeking medical care yet...hopefully it subsides.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chest pain, Echocardiogram, X-ray
Clinical narrative: Intense chest cramps. Seemed to be pericarditis... Pain went away but I went to the doctor with deep concerns over heart issues.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Catheterisation cardiac, Chest X-ray, Chest pain, Dyspepsia
Clinical narrative: 9/21/2021 woke up at 1am with severe heart burn (which I never have)  Pain in chest and neck.  Took Ibuprofen and Papaya.  subsided some and I went to work.  9/22/2021 woke up 2am with severe pain in neck and chest difficult breathing.  2:30 pm drove to Rapid Care thinking it was heart burn but breathing getting much worse.  They sent me to ER across the street, by the time I walked over I was in breathing distress and chest pain. EKG showed heart attack symptoms
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram abnormal, Electrocardiogram abnormal, Myocardial fibrosis, Neck pain
Clinical narrative: 9/21/2021 woke up at 1am with severe heart burn (which I never have)  Pain in chest and neck.  Took Ibuprofen and Papaya.  subsided some and I went to work.  9/22/2021 woke up 2am with severe pain in neck and chest difficult breathing.  2:30 pm drove to Rapid Care thinking it was heart burn but breathing getting much worse.  They sent me to ER across the street, by the time I walked over I was in breathing distress and chest pain. EKG showed heart attack symptoms
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pericarditis, Respiratory distress, Scan
Clinical narrative: 9/21/2021 woke up at 1am with severe heart burn (which I never have)  Pain in chest and neck.  Took Ibuprofen and Papaya.  subsided some and I went to work.  9/22/2021 woke up 2am with severe pain in neck and chest difficult breathing.  2:30 pm drove to Rapid Care thinking it was heart burn but breathing getting much worse.  They sent me to ER across the street, by the time I walked over I was in breathing distress and chest pain. EKG showed heart attack symptoms
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Patient had a history of bad vaccine reactions therefore was monitored for 30 minutes for possible anaphylaxis. No anaphylaxis occurred during that period. After the vaccinator dismissed the patient from observation shortly thereafter the patient developed itchiness. The patient then proceeded to purchase Zyrtec to treat the condition of her own regard. She took 3 doses daily through Sunday.(Friday = dose 1, Sunday = dose 3). The itchiness went away by Sunday evening but then the patient woke up on Monday and had visible hives on the left side of her head all the way extending to her neck. She also had a hive along her temple/hairline on the right side. She reported this to the employee health department of the hospital who advised her to speak with her PCP at the time.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Loss of consciousness, Pain
Clinical narrative: On the day of the vaccine, I passed out in a store and puked in the parking lot. I also experienced extreme chills and headache. My entire body ached for the rest of the day.  On the day after the vaccine I felt much better, but I did have diarrhea.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: On the day of the vaccine, I passed out in a store and puked in the parking lot. I also experienced extreme chills and headache. My entire body ached for the rest of the day.  On the day after the vaccine I felt much better, but I did have diarrhea.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site reaction, Injection site warmth, Pyrexia, Rash erythematous
Clinical narrative: Ran a fever of 102 degrees for 24 hours.  Had a large red rash (hot) at injection site for 6 days.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Fever, chills, headache